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Abstract 27 
Background and purpose. Aldosterone stimulates epithelial Na+ channel (ENaC)-dependent 28 
Na+ retention in the cortical collecting duct (CCD) of the kidney by activating 29 
mineralocorticoid receptors (MR) that promote expression of serum and glucocorticoid-30 
inducible kinase 1 (SGK1). This response is critical to blood pressure homeostasis. It has 31 
previously been suggested that inhibiting lysine deacetylases (KDACs) can post-32 
transcriptionally disrupt this response by promoting acetylation of the MR. The present study 33 
critically evaluates this hypothesis. 34 
Experimental approach. Electrometric and molecular methods were used to define the 35 
effects of a pan-KDAC inhibitor (Trichostatin A; TSA) upon the responses to a 36 
physiologically relevant concentration of aldosterone (3 nM) in murine mCCDcl1 cells. 37 
Key results. Aldosterone augmented ENaC-induced Na+ absorption and increased SGK1 38 
activity and abundance, as expected. In the presence of TSA these responses were 39 
suppressed. TSA-induced inhibition of KDAC was confirmed by increased acetylation of 40 
histone H3, H4 and -tubulin. TSA did not block the electrometric response to insulin, a 41 
hormone that activates SGK1 independently of increased transcription, indicating that TSA 42 
has no direct effect upon the SGK1 / ENaC pathway. 43 
Conclusions and implications. Inhibition of lysine acetylation suppresses aldosterone-44 
dependent control over the SGK1-ENaC pathway, but does not perturb post-transcriptional 45 
signalling, providing a physiological basis for the anti-hypertensive action of KDAC 46 
inhibition seen in vivo. 47 
Key words: Histone deacetylase, lysine deacetylase, aldosterone, cortical 48 
collecting duct, epithelial Na+ channel (ENaC), sodium transport.   49 
Abbreviations 50 
CCD Cortical collecting duct 51 
DOCA   Deoxycorticosterone acetate 52 
ENaC   Epithelial Na+ channel 53 
HDAC   Histone deacetylase 54 
HEK   Human embryonic kidney 55 
Iamil    Amiloride-sensitive current 56 
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Ieq    Equivalent short circuit current 57 
KAT   Lysine acetyl transferase 58 
KDAC  Lysine deacetylase 59 
KDACi  Lysine deacetylase inhibitor 60 
MR    Mineralocorticoid receptor 61 
NDRG1  N-myc downstream regulated gene 1 62 
GR    Glucocorticoid receptor 63 
SGK1 Serum- and glucocorticoid-inducible kinase 1 64 
Rt    Transepithelial resistance 65 
TSA Trichostatin A 66 
Vt    Transepithelial voltage 67 
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 83 
What is already known? 84 
 Aldosterone stimulates Na+ retention by activating mineralocorticoid receptors (MR) 85 
in the cortical collecting duct (CCD) 86 
 This anti natriuretic response depends upon MR-mediated changes in gene expression 87 
What this study adds 88 
 As anticipated, TSA consistently promoted acetylation of cytoplasmic and nuclear 89 
proteins 90 
 Trichostatin A (TSA) supressed the MR-mediated transcription of sgk1 and blocked 91 
aldosterone-induced Na+ absorption 92 
Clinical significance 93 
 Hypertension can be treated with drugs that disrupt the response to aldosterone 94 
 Agents that promote protein acetylation may provide a novel means of supressing 95 
aldosterone-induced Na+ retention 96 
  97 
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Introduction 98 
Protein acetylation is a post translational modification, catalysed by lysine acetyl transferases 99 
(KATs, also known as histone acetyl transferases, HATs), that convert positively charged 100 
amine groups in lysine residues into neutral amides (see review Falkenberg et al., 2014). The 101 
subsequent removal of acetyl residues from proteins modified in this way is catalysed by 102 
lysine deacetylases (KDACs, also known as histone deacetylases, HDACs) a zinc-dependent 103 
enzyme family (Falkenberg et al., 2014). The acetylation status of many cellular proteins is 104 
therefore determined by the relative activities of KATs / KDACs and the acetylation of many 105 
cytoplasmic proteins has physiological relevance. Acetylation of the glucocorticoid receptor 106 
(GR), for example, modifies the hormone-induced transcription of several genes (Kadiyala et 107 
al., 2013; Winkler et al., 2012) whilst acetylation of the cytoplasmic receptors for oestrogen, 108 
progesterone and testosterone reduces the ability of sex steroids to regulate gene 109 
transcription, an effect that is exploited to suppress the growth of hormone-sensitive tumour 110 
cells (Falkenberg et al., 2014). Changes to the acetylation status of cytoplasmic receptors 111 
therefore provide a means of modifying responses to steroid hormones (Barnes, 2013; 112 
Falkenberg et al., 2014). 113 
Mineralocorticoid receptors (MR) in the cortical collecting duct (CCD) allow aldosterone to 114 
promote renal Na+ reabsorption by evoking expression of genes, such as that encoding serum 115 
and glucocorticoid-inducible kinase 1 (SGK1) (Lang et al., 2006), that control the abundance 116 
of epithelial Na+ channel (ENaC) subunits at the apical membrane (Alvarez De La Rosa et 117 
al., 2002; Blazer-Yost et al., 1998; Lang et al., 2009; Loffing et al., 2009; Soundararajan et 118 
al., 2009; Soundararajan et al., 2007; Soundararajan et al., 2005). The MR-SGK1-ENaC 119 
pathway is critical to the long-term regulation of blood pressure and many drugs used to treat 120 
hypertension (ACE inhibitors, MR antagonists) promote diuresis / natriuresis by disrupting 121 
this mechanism. It is therefore interesting that KDAC inhibitors (KDACi) promote 122 
acetylation of heterologously expressed MR and reduce the transcriptional activity of this 123 
protein (Lee et al., 2013). Moreover, KDACi also suppress aldosterone-induced gene 124 
transcripts in human embryonic kidney (HEK) cells, apparently by promoting acetylation of 125 
the endogenous MR (Lee et al., 2013). Furthermore, such substances also block the 126 
development of hypertension in unilaterally nephrectomised mice exposed to a high salt diet 127 
and injected with DOCA (deoxycorticosterone acetate), an MR agonist (Lee et al., 2013).  128 
Whilst this work suggests KDACi might lower blood pressure by suppressing aldosterone-129 
induced Na+ retention (Lee et al., 2013), it is important to note that HEK cells, although 130 
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derived from renal tissue, do not display a phenotype representative of any nephron segment. 131 
Indeed, these cells express voltage-gated Na+ channels suggesting that they display a neural, 132 
rather than an epithelial phenotype (Mansell et al., 2011; Moran et al., 2000). Although 133 
aldosterone did induce gene expression in these cells (Lee et al., 2013), the effect upon SGK1 134 
developed over ~24 h (Lee et al., 2013) and this extremely slow response is in stark contrast 135 
with data from CCD cells where hormone-induced Na+ transport is apparent after only ~1 h. 136 
This relatively rapid response is accompanied by large (~40 fold) increases in the abundance 137 
of SGK1 mRNA and protein, and a clear increase in cellular SGK1 activity (Lang et al., 138 
2009; Lang et al., 2006; Mansley et al., 2016). It is therefore difficult to relate the effects of 139 
KDACi on HEK cells to events within the CCD. In order to test the hypothesis that KDAC 140 
inhibitors are able to suppress the MR-mediated stimulation of Na+ absorption in the CCD, 141 
we have now explored the effects of Trichostatin A (TSA), a pan-KDACi, upon the responses 142 
to physiologically relevant concentrations of aldosterone in mouse CCD cells (mCCDcl1). 143 
Materials and methods 144 
Electrophysiological measurements 145 
Standard methods were used to maintain murine mCCDcl1 cells in serial culture (Mansley et 146 
al., 2015) and experiments undertaken using confluent cells (7 – 8 days culture) that had been 147 
deprived of hormones / growth factors for ~48 h (Gaeggeler et al., 2005; Mansley et al., 148 
2015). ENaC-mediated Na+ transport was usually quantified in cells grown on Transwell 149 
membranes by measuring transepithelial voltage (Vt) and resistance (Rt) using an epithelial 150 
volt-ohm-meter (WPI EVOM2, Hitchin, Herts., UK). Some experiments were undertaken 151 
using cells grown on Costar Snapwell membranes that were mounted in Ussing chambers 152 
where Vt and Rt were monitored continuously (Mansley et al., 2010b). Equivalent short 153 
circuit current (IEq) was then calculated from Ohm’s Law (i.e. Vt / Rt). All electrometric 154 
experiments were terminated by adding amiloride (10 µM), an ENaC blocker, to the solution 155 
bathing the apical side of the membrane. The small current (~5% of control) that persisted 156 
under these conditions was then subtracted from the previously measured values of IEq to 157 
quantify the transepithelial Na+ current flowing via ENaC (IAmil). Since Vt was expressed 158 
relative to an earth electrode in the basolateral bath, the absorption of Na+ moving from the 159 
apical to the basal compartment will generate negative current. 160 
Western analysis of extracted protein 161 
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Confluent cells were washed three times with ice cold phosphate-buffered saline before being 162 
scraped into ice cold lysis buffer containing protease and phosphatase inhibitors (Mansley et 163 
al., 2010b). The cellular lysates were then ultrasonicated to ensure disruption, centrifuged to 164 
remove insoluble debris and their protein contents determined (Bradford reagent, Bio-Rad, 165 
Hertfordshire, UK). Aliquots of extracted protein (40 µg) were then fractionated on sodium 166 
dodecyl sulphate – polyacrylamide gels and transferred to Hybond PVDF membranes that 167 
were probed using antibodies detailed below. Immunoreactive proteins were detected using 168 
peroxide-conjugated secondary antibodies / enhanced chemiluminescence (ECL). Once this 169 
analysis was complete, gels were stripped and then re-probed using antibodies against -actin 170 
or total NDRG1 to provide markers of protein loading. Fuller details are provided elsewhere 171 
(Mansley et al., 2016; Mansley et al., 2010b). 172 
Protein samples derived from each experiment were processed in parallel and analysed on the 173 
same gels. This was important since Western analysis cannot produce entirely uniform data 174 
and ensuring that samples from entire experiments were analysed together therefore 175 
guarantees that variations between batches of antibody, ECL reagents, efficiencies of protein 176 
transfer to blotting membranes etc. do not contribute to the observed variation within each 177 
experimental group. It is evident from the presented images that some of the antibodies used 178 
identified additional bands in certain experiments. These additional bands were unaltered by 179 
any experimental manoeuvres and were therefore assumed to be irrelevant to the present 180 
study and ignored in our analyses. To derive quantitative data, high resolution, uncompressed 181 
digital images (TIF format) of each developed blot were obtained using a Chemi DOC MP 182 
Imaging System (BioRad, Hemel Hemptead, Herts. UK). The optical densities of all relevant 183 
bands were measured digitally (ImageJ, RRID:SCR_003070) and the data from each series of 184 
experiments collated. The mean optical density associated with protein extracted from cells 185 
deprived of hormones throughout the entire experimental period (i.e. control) was then 186 
determined. The individual data points from the entire series of experiments, whether from 187 
control or experimental cells, were then normalised to this overall mean value. The results of 188 
all such experiments are therefore expressed relative to a mean control signal. The effects of 189 
TSA upon the abundance of each acetylated protein were quantified densitometrically using 190 
ImageJ (Rueden et al., 2017) using the expression ODTSA – Control / ODMax – ODControl. In this 191 
expression ODTSA refers to the optical density quantified in cells exposed to a particular 192 
concentration of TSA, whist ODControl and ODMax respectively refer to the corresponding 193 
values from control cells (i.e. cells simply exposed to solvent vehicle) and cells exposed to a 194 
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maximally-effective concentration of TSA. The results of this analysis are plotted (Fractional 195 
response, mean ± 95% CI) against the concentration of TSA. The presented images show 196 
individual gels judged to represent the results obtained in the entire series of experiments. 197 
None of these images were manipulated in such a way to conceal, move or introduce any 198 
specific feature. Cited molecular weights were estimated by reference to standards that were 199 
run on each gel. 200 
Data and Statistical analysis 201 
The effects of TSA upon responses to hormones were explored using strictly paired protocols 202 
in which control cells were exposed to a relevant concentration of the appropriate solvent 203 
vehicle. For all experiments, cells were grown on filters matched by: passage number, date of 204 
thaw, seeding density and culture conditions. For experiments, each matched filter of cells 205 
was randomly allocated to an experimental group, and values of n refer to the number of 206 
times the entire protocol was repeated. Pooled data are shown as mean ± the 95% confidence 207 
interval (95% CI) and the results of individual experiments are shown in all figures. 208 
Statistical analysis was undertaken using GraphPad Prism 7.03 (Graph Pad Software Ltd., 209 
San Diego, CA, USA. RRID:SCR_002798). Where appropriate, the pooled data derived from 210 
each set of experiments were firstly analysed by 2 way ANOVA. If this analysis identified 211 
statistically significant variations between the experimental groups, we undertook further 212 
analysis using Tukey’s post hoc test with correction for multiple comparisons in order to 213 
identify differences between particular experimental groups. Values of P < 0.05 were 214 
considered to indicate statistical significance. The data and statistical analysis comply with 215 
the recommendations on experimental design and analysis in pharmacology (Curtis et al., 216 
2015). 217 
Experimental materials 218 
Amiloride, aldosterone, insulin and general laboratory reagents were from Sigma (Poole, 219 
Dorset, UK). Antibodies against the Thr346/356/366-phosphorylated and total forms of the 220 
protein encoded by n-myc downstream regulated gene 1 (NDRG1) and against SGK1 were 221 
purchased from the MRC Protein Phosphorylation Unit, University of Dundee (Dundee, UK). 222 
The antibodies against -actin (RRID:AB_476697) and acetylated -tubulin 223 
(RRID:AB_609894) were from Sigma (Poole, Dorset, UK), the antibodies against acetylated 224 
histone H3 (RRID:AB_823528) and H4 (RRID:AB_2448400) were from Cell Signalling 225 
Technologies (Leiden, The Netherlands). 226 
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 227 
Nomenclature of Targets and Ligands  228 
Key protein targets and ligands in this article are hyperlinked to corresponding entries in 229 
http://www.guidetopharmacology.org, the common portal for data from the IUPHAR/BPS 230 
Guide to PHARMACOLOGY (Harding et al., 2018), and are permanently archived in the 231 
Concise Guide to PHARMACOLOGY 2017/18 (Alexander et al., 2017a; Alexander et al., 232 
2017b; Alexander et al., 2017c). 233 
Results 234 
The response of CCD cells to aldosterone 235 
Table 1 shows the results of electrometric experiments that explored the effects of 236 
aldosterone (3 nM, 3 h) on cells grown on Transwell membranes. Aldosterone hyperpolarized 237 
Vt and reduced Rt and analysis using Ohm’s Law revealed a clear increase in the magnitude 238 
of IEq (Table 1). Subsequently exposing unstimulated and aldosterone-stimulated cells to 239 
apical amiloride (10 µM), an ENaC blocker, depolarized Vt, increased Rt and caused >90% 240 
block of IEq (Table 1). Whilst these findings confirm that IEq is due, almost exclusively, to 241 
electrogenic Na+ absorption via ENaC, it is interesting that aldosterone did augment the small 242 
current that persisted in the presence of amiloride (Table 1). The physiological basis of this 243 
small, amiloride resistant current was not investigated, but it is possible that it reflects the 244 
secretion of Cl- and / or HCO3- across the apical membrane. To complete the analysis of 245 
these data, we quantified IAmil (see Methods) and our data show clearly that aldosterone 246 
causes a 2.7 ± 0.2 fold increase (mean ± 95% CI) in the magnitude of this current 247 
(unstimulated: -7.5 ± 1.3 µA cm-2; aldosterone-stimulated: -20.2 ± 3.0 µA cm-2, n = 12, mean 248 
± 95% CI, P < 0.05 Student’s unpaired t test). 249 
TSA-induced acetylation of cellular proteins 250 
TSA was one of the first KDAC inhibitors to be described (Yoshida et al., 1990) and is 251 
widely used as a reference in research within this field. It has been used to determine anti-252 
tumour activity in pre-clinical models of cancer but it has not been assessed in a clinical 253 
setting (Sanderson et al., 2004). Studies of protein extracted from hormone-deprived cells 254 
exposed to TSA (0.01 – 100 µM) and / or solvent vehicle for 6 h showed that this pan-255 
KDACi increased the abundance of acetylated histone H3 (Fig 1A), histone H4 (Fig 1B) and 256 
-tubulin (Fig 1C). Analysis of sigmoid curves fitted to these data by least squares regression 257 
(Fig 1A – C) showed that half maximal responses occurred at ~0.15 µM (histone H3: EC50 = 258 
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0.14 ± 0.07 µM; histone H4: EC50 = 0.15 ± 0.19 µM; -tubulin: EC50 = 0.20 µM ± 0.13 µM) 259 
and established that concentrations of TSA > 1 µM were maximally effective (Fig 1A – C). 260 
Parallel analyses using an antibody against -actin confirmed that identical amounts of 261 
protein had been loaded onto each gel (Fig 1D) and we therefore conclude that exposure to 262 
TSA promotes acetylation of all three proteins. Fig 2 shows that the effects on histone H3 and 263 
H4 became apparent after ~1 h and reached plateau values after 6 – 12 h (Fig 2A, B). The 264 
acetylation of -tubulin, on the other hand, peaked at ~1 h (Fig 2C). Although the effects on 265 
all three proteins declined throughout the remainder of the experimental period, increased 266 
acetylation persisted until at least 24 h (Fig 2A – C). Parallel analyses using the -actin 267 
antibody confirmed that essentially identical amounts of cellular protein had been loaded onto 268 
each gel (Fig. 2D). 269 
TSA disrupts the electrometric response to aldosterone 270 
We explored the effects of TSA (1 µM) upon the electrometric response to aldosterone using 271 
the experimental protocol shown in Fig 3A. Measurements made at the onset of these 272 
experiments showed that IEq was normally ~8 µA cm
-2 (Fig 3B) and this parameter was 273 
unaffected by exposure (2 h) to 1 µM TSA (Fig 3C). Control and TSA-treated cells were then 274 
exposed to 3 nM aldosterone and / or solvent vehicle and the electrometric measurements 275 
repeated after a further 3 h. Whilst the control data confirmed that aldosterone normally 276 
augments IEq (Fig 3D), this hormone had only very small effects on TSA-treated cells (Fig 277 
3D). Further analysis of these data confirmed (Mansley et al., 2015) that aldosterone 278 
normally augments IAmil (Fig 3F). Although a small response was seen in the TSA-treated 279 
cells, its magnitude was only 15.7 ± 1.0 % of control (Fig 3) and therefore we conclude that 280 
TSA causes substantial (~85%) loss of sensitivity to aldosterone. 281 
The control of cellular SGK1 abundance / activity 282 
Cellular SGK1 activity was assessed using an established method that is based upon the 283 
identification of residues within an endogenous protein (NDRG1-Thr346/356/366) that are 284 
phosphorylated by SGK1 but not by other, closely related kinases (Inglis et al., 2009; Murray 285 
et al., 2004). Once the electrometric measurements described above were completed, protein 286 
was extracted from cells for Western analysis so that we could correlate the electrometric 287 
data with changes to the phosphorylation status of these residues. These experiments showed 288 
clearly that the aldosterone-induced augmentation of IAmil was associated with an increase in 289 
the abundance of Thr346/356/366-phosphorylated NDRG1 (Fig 4A) that occurred without change 290 
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to the overall NDRG1 expression level (Fig 4A). Aldosterone thus promotes phosphorylation 291 
of NDRG1-Thr346/356/366 and this finding confirms (Inglis et al., 2009; Murray et al., 2004) 292 
that this hormone normally increases cellular SGK1 activity. No such response was seen in 293 
TSA-treated cells (Fig 4). Parallel analyses using an antibody against SGK1 itself showed 294 
that aldosterone also increased the abundance of SGK1 protein and analyses undertaken using 295 
the -actin antibody confirmed that this effect could not be attributed to variations in the 296 
mass of protein loaded onto the gels (Fig 4B). Aldosterone therefore increases the abundance 297 
of this protein and this response, in common with the associated increase in cellular SGK1 298 
activity, was abolished by TSA (Fig 4B). 299 
Effects of TSA upon the response of CCD cells to insulin 300 
Fig 5A shows continuous records of IAmil derived from cells mounted in Ussing chambers and 301 
acutely exposed to insulin (20 nM). As anticipated (Faletti et al., 2002; Gonzalez-Rodriguez 302 
et al., 2007; Mansley et al., 2016; Mansley et al., 2010b; Record et al., 1998), insulin caused 303 
a clear and rapid augmentation of IAmil although the response (ΔIAmil ~ 11 µA cm-2, Fig 5A) 304 
was smaller than the response to aldosterone. Fig 5A also includes data from experiments 305 
undertaken using age-matched cells pre-treated (2 h) with 1 µM TSA. The responses seen in 306 
these cells were essentially identical to control indicating that TSA does not modify the 307 
electrometric response to this hormone. The insulin-induced augmentation of IAmil was 308 
associated with an increase in the abundance of Thr346/356/366-phosphorylated NDRG1 (Fig 309 
5B) that occurred with no change to the overall NDRG1 expression level (Fig 5B). These 310 
data accord with previous findings (Mansley et al., 2010a; Mansley et al., 2010b) and 311 
therefore confirm that insulin normally activates SGK1 in CCD cells. This response persisted 312 
in the presence of TSA (1 µM), a novel finding which shows that insulin can still activate 313 
SGK1 following KDAC inhibition. 314 
Discussion 315 
Design of the present study 316 
The controlled reabsorption of Na+ within the CCD is critical to blood pressure homeostasis 317 
and depends upon ENaC, a Na+-selective channel present in the apical membrane of principal 318 
cells in the CCD. In unstimulated cells the amount of ENaC in this membrane is restricted by 319 
the continual internalisation of channel subunits and this internalisation process limits the Na+ 320 
permeability of the apical membrane and restricts the amount of Na+ that can be recovered 321 
from the tubular fluid. Aldosterone promotes Na+ retention by binding to the MR and 322 
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inducing expression of several genes, including that encoding SGK1 (Lang et al., 2006). 323 
Although other mechanisms may well be involved (Frindt et al., 2016; Soundararajan et al., 324 
2012), a substantial body of work shows that increased cellular SGK1 activity can inhibit this 325 
ENaC internalisation mechanism and thus allow the Na+ permeability of the apical membrane 326 
to rise. This, in turn, increases the amount of Na+ recovered from the tubular fluid 327 
(Debonneville et al., 2001; Snyder, 2005; Snyder et al., 2004). Earlier studies of cultured 328 
CCD cells showed that the natriuretic responses to aldosterone and insulin were abolished by 329 
pharmacological inhibition of SGK1 (Mansley et al., 2018; Mansley et al., 2010b), and this 330 
cannot be attributed to a nonspecific effect since the responses to peptide hormones that 331 
signal via cAMP / PKA are preserved when signalling via SGK1 is blocked. Hormone-332 
induced changes to cellular SGK1 activity are therefore central to the regulation of Na+ 333 
retention. 334 
Administration of KDACi was shown to abolish the high blood pressure seen in a mouse 335 
model of hypertension, an observation attributed to loss of MR function (Lee et al., 2013). 336 
This therefore implied that KDAC inhibition would abolish MR-mediated activation of the 337 
SGK1-ENaC pathway in the CCD. The aim of the present study was to test this hypothesis 338 
using a clinically applicable in vitro model of CCD cells, the mCCDcl1 cell line. Our initial 339 
experiments were thereby focused on characterisation of the control response of these cells to 340 
aldosterone. Relatively brief (3 h) exposure of these cells to this hormone clearly augmented 341 
ENaC-mediated Na+ transport and so, in contrast to HEK cells (Lee et al., 2013), mCCDcl1 342 
cells display a relatively rapid response to aldosterone. Since the concentration of aldosterone 343 
used (3 nM) approximates to the circulating concentration in salt-deprived mice (Bertog et 344 
al., 2008; Gaeggeler et al., 2005), these data also confirm that mCCDcl1 cells are sensitive to 345 
physiologically-relevant concentrations of this hormone (Mansley et al., 2018). This point is 346 
significant to the present study since high concentrations of aldosterone (> ~10 nM) activate 347 
the GR as well as MR (Gaeggeler et al., 2005). We estimate (Gaeggeler et al., 2005) that 3 348 
nM aldosterone will provide essentially complete (>~90%) occupancy of the MR but 349 
negligible binding to the GR, and therefore attribute the present responses to MR-mediated 350 
stimulation of Na+ transport via ENaC.  351 
Analysis of protein extracted from TSA-treated cells revealed clear increases in the 352 
abundance of acetylated histone H3 and H4, these are nuclear proteins that are archetypical 353 
class I KDAC substrates demonstrated in several cell types (Bantscheff et al., 2011; Vigushin 354 
et al., 2001; Yoshida et al., 1995). In addition to nuclear proteins, TSA treatment also 355 
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increased abundance of acetylated -tubulin in mCCDcl1 cells, a protein target of class II 356 
KDACs. Moreover, whilst the acetylation of nuclear histone H3 / H4 proteins developed over 357 
~6 h, the acetylation of -tubulin developed over a much shorter time period (~1 h). This 358 
observation supports the reported mechanistic basis of KDAC activity and the requirement 359 
for class I KDACs to translocate to the nuclear compartment to exert their effect upon 360 
histones, as opposed to cytoplasmic proteins which can be directly modified. 361 
The ability of the pan-KDACi TSA to modify both cytoplasmic and nuclear proteins, in 362 
combination with our earlier studies, confirming a physiologically relevant response of the 363 
mCCDcl1 cells to MR activation, allowed us to thereby design a protocol to test the theory 364 
that KDACi suppress MR-mediated activation of the SGK1-ENaC pathway in CCD cells. 365 
Aldosterone normally increased the magnitude of IAmil by ~2.5 fold and the 95% confidence 366 
interval associated with this response was ~0.2 fold. This implies that the smallest inhibitory 367 
action detectible by our study is ~20%. However, the previously reported animal studies had 368 
indicated that administration of KDACi essentially abolished experimental hypertension (Lee 369 
et al., 2013) which, if correctly attributed to loss of MR function, would predict that KDAC 370 
inhibition associates with substantial inhibition of the response to aldosterone. Our 371 
experimental protocol therefore has sufficient statistical power to allow us to properly 372 
evaluate this hypothesis. 373 
TSA supresses the response to aldosterone without directly affecting SGK1–ENaC  374 
TSA caused substantial (~85%) inhibition of the electrometric response to aldosterone and 375 
abolished the associated increases in the abundance and activity of SGK1. These findings are 376 
consistent with the hypothesis that inhibition of KDACs cause loss of MR function (Lee et 377 
al., 2013). Although aldosterone is the principal regulator of ENaC in the CCD, insulin also 378 
promotes Na+ absorption via a mechanism dependent on the SGK1-ENaC signalling pathway 379 
(Blazer-Yost et al., 2003; Blazer-Yost et al., 1998; Blazer-Yost et al., 1992; Faletti et al., 380 
2002; Mansley et al., 2016; Mansley et al., 2010a; Pearce et al., 2007; Record et al., 1998; 381 
Wang et al., 2001). However, despite both hormones increasing cellular SGK1 activity, TSA 382 
did not perturb the response to insulin. In contrast to aldosterone, insulin activates SGK1 383 
without increasing the abundance of SGK1 protein or mRNA. Instead, this hormone acts via 384 
a non-genomic mechanism dependent upon PI3K (Cohen, 2006) an enzyme that increases the 385 
catalytic activity of SGK1 protein by controlling its phosphorylation (Kobayashi et al., 1999; 386 
Park et al., 1999). TSA therefore suppresses MR-mediated activation of the SGK1-ENaC 387 
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pathway by disrupting control over SGK1 protein abundance without affecting the PI3K-388 
dependent, post-translational control of this pathway. 389 
The mechanism that allows aldosterone to regulate ENaC-mediated Na+ retention is complex 390 
and incompletely understood. However, it is now clear that the acetylation status of cellular 391 
proteins has a direct bearing upon several components of this pathway. For example, KDAC 392 
inhibition has been shown to promote acetylation of heat shock protein 90 (hsp90), a protein 393 
that controls the translocation of activated steroid receptors to the nucleus (Barnes, 2013; 394 
Jimenez-Canino et al., 2016). Moreover, in contrast to the studies of wild type / mutant forms 395 
of the MR (Lee et al., 2013), this works indicates that KDAC inhibitors do not alter the 396 
transcriptional activity of the receptor (Jimenez-Canino et al., 2016). The inhibition of MR 397 
signalling which we now report may therefore be due, at least in part, to altered translocation 398 
of the MR between the cytoplasm and the nucleus (Jimenez-Canino et al., 2016). However, 399 
KDAC inhibition has also been shown to promote acetylation of ENaC itself (Butler et al., 400 
2015). This modification seems to block the ENaC internalisation process that appears to 401 
limit Na+ transport in unstimulated cells (Blazer-Yost et al., 2005; Gonzalez-Rodriguez et al., 402 
2007; Wang et al., 2001). Rather than supressing Na+ absorption, these data therefore suggest 403 
that ENaC acetylation will augment Na+ retention by increasing the surface abundance of the 404 
channel (Butler et al., 2015). Whilst we cannot exclude the possibility that this process may 405 
augment Na+ retention under certain conditions (Butler et al., 2015), our data show that TSA 406 
has no effect on basal Na+ transport and does not modify the response to insulin. It thus 407 
appears that inhibition of KDAC does not directly modify ENaC function under the present 408 
conditions. 409 
The KDAC enzyme family contain at least 8 members (KDAC1 – 8) and it is now clear that 410 
different KDACs can fulfil different physiological roles. The acetylation status of the MR, for 411 
example, seems to be maintained by KDAC3 (Lee et al., 2013), whilst KDAC6 and KDAC5 412 
are respectively thought to determine the acetylation status of hsp90 (Jimenez-Canino et al., 413 
2016) and ENaC (Butler et al., 2015). TSA is a broad spectrum KDAC inhibitor, and thus has 414 
the potential to interfere with all of these events. Moreover, although selective inhibitors are 415 
becoming available, their use is not straightforward since the KDAC isoforms are known 416 
interact with each other. For example, although acetylated -tubulin is not a substrate for 417 
KDAC3, MI192, a highly selective inhibitor of KDAC3 (Boissinot et al., 2012), promotes 418 
acetylation of this protein via an indirect mechanism that is ultimately dependent upon 419 
KDAC6 (Bacon et al., 2015). 420 
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Conclusions and implications 421 
TSA promoted the acetylation of nuclear (histone H3, H4) and cytoplasmic (-tubulin) 422 
proteins indicating clear inhibition of KDAC. Moreover, TSA also blocked the aldosterone-423 
dependent control over ENaC-mediated Na+ transport and cellular SGK1 activity, but did not 424 
affect the corresponding responses to insulin. The present data therefore show that TSA 425 
selectively disrupts the regulation of Na+ transport via genomic mechanisms. These data 426 
accord with studies of the heterologously expressed MR (Lee et al., 2013) and establish a 427 
physiological basis for the antihypertensive actions seen in vivo (Lee et al., 2013). KDAC 428 
inhibition may therefore provide a novel means of lowering blood pressure in hypertensive 429 
patients and it is therefore important to fully define the mechanisms that allow these 430 
compounds to act in this way. The effects described in this earlier study (Lee et al., 2013) 431 
were attributed to increased acetylation of the MR itself and, although we did not directly 432 
monitor the acetylation status of this receptor, MR acetylation could well explain the 433 
inhibitory action of TSA described here. However, it is important to stress that genomic 434 
responses to steroids such as aldosterone occur via complex mechanisms that are still 435 
incompletely understood. In this context it is interesting that inhibition of KDAC5/6 appears 436 
to suppress the translocation of the activated MR from the cytoplasm into the nucleus without 437 
altering the transcriptional activity of the receptor itself (Jimenez-Canino et al., 2016). We 438 
cannot exclude the possibility that such a mechanism may contribute to the effect of TSA 439 
which we now report and it is also possible that the response may reflect changes to the 440 
acetylation of histone itself. Future studies, in which the acetylation status of the MR along 441 
with other physiologically important proteins are critically assessed, will therefore be 442 
required to establish the mechanism that allows TSA to suppress aldosterone-induced Na+ 443 
transport. 444 
  445 
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 659 
Table 1: The electrometric response to aldosterone 
 Vt (mV) Rt (Ω cm-2) Ieq (µA cm-2) 
 Baseline 3h treatment Amil. Baseline 3h treatment Amil. Baseline 3h treatment Amil. 
Vehicle -17.2 ± 5.9 -16.3 ± 5.1  0.5 ± 0.7Ϯ 2105 ± 342 2125 ± 363 3340 ± 650 Ϯ -7.8 ± 1.6 -7.4 ± 1.4 0.1 ± 0.2 Ϯ 
Aldo. -18.1 ± 5.2 -36.7 ± 7.4* -5.9 ± 3.2* Ϯ 2277 ± 257 1666 ± 113* 3261 ± 461 Ϯ -7.7 ± 1.5 -5.9 ± 3.2* -1.6 ± 0.8* Ϯ 
Electrometric measurements (Vt and Rt) were recorded, allowing calculation of equivalent short circuit current (Ieq), from cells grown on filters 
under control (vehicle) or aldosterone-treated conditions. Measurements were made: before treatment (baseline); 3 h after treatment (3h 
treatment) with solvent vehicle or aldosterone (Aldo, 3 nM); and 5 min after exposure to amiloride (Amil., 10 µM). Data are mean ± 95% 
confidence interval (n = 12), statistical significance was determined using a repeated-measures two-way ANOVA. Where appropriate, multiple 
comparisons were determined by Tukey’s post-hoc test and significance has been denoted for comparisons between vehicle and aldosterone-
treated cells (*) or comparisons of 3h treatment and amiloride (Ϯ).  
 660 
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Figure Legends 661 
Fig 1. TSA-induced acetylation of cellular proteins. Cells were exposed to TSA (0.01 – 662 
100 µM) and / or solvent vehicle for 6 h. Upper panels show representative blots probed with 663 
acetylated histone H3 (A, Ac-Histone H3), histone H4 (B, Ac – Histone H4) and -tubulin 664 
(C, Ac--tubulin). All blots were reanalysed using an antibody against -actin (D).  665 
Molecular weight markers are marked and arrows denote relevant bands. Lower panels show 666 
the densitometric analyses of the data derived from the entire series of experiments (n = 5). 667 
The solid curves are sigmoid curves fitted to these data by least squares regression whilst the 668 
vertical bars are centred on the mean values and show the 95% confidence interval. The mean 669 
densitometric values of -actin are expressed relative to the mean value from cells treated 670 
with solvent vehicle of TSA. 671 
Fig 2. Time course of TSA-induced acetylation. Protein extracted from cells exposed to 672 
1 µM TSA for 0 – 24 h was subject to Western analysis using antibodies against the 673 
acetylated forms of histone H3 (A, Ac-Histone H3, n = 6), histone H4 (B, Ac – Histone H4, n 674 
= 6) and -tubulin (C, Ac--tubulin, n = 6). All blots were then re-probed using the antibody 675 
against -actin (D). In each figure the upper panel shows the results of a representative 676 
experiment whilst the densitometric analyses presented below show the changes to the 677 
abundance of each protein plotted against time. Data are mean ± 95% CI. 678 
Fig 3. Effects of TSA upon the electrometric response to aldosterone. (A) Each 679 
horizontal bar represents a separate cultured epithelial layer and cells were exposed to TSA, 680 
aldosterone and amiloride as indicated by the different shading. Electrometric data were 681 
recorded (arrows) at the onset of each experiment (B); after 2 h exposure to TSA (1 µM) and 682 
/or solvent vehicle (C); after the cells had been exposed to aldosterone (3 nM) and / or 683 
solvent vehicle for a further 3 h (D), and after a final application of 10 µM apical amiloride 684 
(E). Shading of the vertical bars (B-D) corresponds with those used in (A) to differentiate the 685 
various stages of the experiment. Vertical columns show the mean values ± 95% CI (n = 7) 686 
for each experimental group. Statistical significance was determined by repeated measures 687 
two-way ANOVA and, where appropriate, multiple comparisons were determined by 688 
Tukey’s post-hoc test. (F) The amiloride-sensitive component of the transepithelial 689 
equivalent current (IAmil, mean ± 95% CI, n = 7) was quantified. Statistical significance was 690 
determined by two-way ANOVA and, where appropriate, multiple comparisons were 691 
determined by Tukey’s post-hoc test. 692 
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Fig. 4. Effects of TSA upon aldosterone-induced SGK1 activity and abundance. (A) 693 
Typical blots obtained using antibodies against the Thr346/356/366-phosphorylated form of the 694 
protein encoded by N-myc downstream regulated gene 1 (upper panel, NDRG1-P-695 
Thr346/356/366) and the equivalent full length protein (lower panel, T-NDRG1). (B) Typical 696 
blots obtained using antibodies against the serum and glucocorticoid-inducible kinase 1 697 
(upper panel, T-SGK1) and -actin (lower panel). Pooled data (right-hand panels) from the 698 
entire series of experiments showing (mean ± 95% CI, n = 5) the effects of aldosterone (3 699 
nM, 3 h) upon the abundance of (A) NDRG1-P-Thr346/356/366 (upper) and total NDRG1 700 
(lower) or (B) SGK1 (upper) and b-actin (lower) in control and TSA-treated (1 µM , 2 h) 701 
cells. Statistical significance was determined by two-way ANOVA and, where appropriate, 702 
multiple comparisons were determined by Tukey’s post-hoc test. 703 
Fig. 5. Insulin-induced Na+ transport and SGK1 activity. (A) Confluent cells on Costar 704 
Snapwell membranes were mounted in Ussing chambers so that the effects of insulin (20 nM) 705 
upon IAmil could be continuously recorded (mean ± 95% CI, n = 6) under control conditions 706 
(left panel) and in cells that had been pre-treated (2 h) with 1 µM TSA (middle panel). The 707 
amiloride-sensitive responses to insulin (ΔIAmil) were quantified and presented as mean ± 708 
95% CI (right panel). (B) Typical blots obtained using antibodies against the Thr346/356/366-709 
phosphorylated form of the protein encoded by N-myc downstream regulated gene 1 (upper 710 
panel, NDRG1-P-Thr346/356/366) and the equivalent full length protein (lower panel, T-711 
NDRG1). Pooled data (right-hand panels) from the entire series of experiments showing 712 
(mean ± 95% CI, n = 6) the effects of insulin (20 nM, 1 h) upon the abundance of NDRG1-P-713 
Thr346/356/366 (upper) and total NDRG1 (lower) in control and TSA-treated (1 µM , 2 h) cells. 714 
Statistical significance was determined by two-way ANOVA and, where appropriate, 715 
multiple comparisons were determined by Tukey’s post-hoc test. 716 
